The University of Virginia Cancer Center is conducting a clinical research study for adults ages 18 and over who have prostate cancer, a rising PSA level after treatment and have specific genotype called Manganese SuperOxide Dismutase Gene (MSOD A/A gene.) The purpose of this study is to find out if Muscadine supplements can slow down the growth rate of prostate cancer in patients with the MSOD gene.
Initially, participation may last up to 11 months, however, it may be extended for up to an additional year depending on how patients respond to treatment. Study specific tests will be provided at no cost to you.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT03535675